Prostate gland inflammation, when confirmed by laboratory tests, becomes diagnosed as "prostatitis." It is one of the most frequently diagnosed pathologies of the male reproductive system, which also leads to a sharp decrease in a man's quality of life, affecting many areas of their health and daily activities. In the urological profile of men over 50, only benign prostatic hyperplasia (BPH) and prostate cancer occur more frequently.

Acute bacterial prostatitis is a severe inflammatory disease that leads to a significant decrease in the quality of life for any patient. In 90% of cases, it occurs spontaneously, against a backdrop of general well-being following various urological (even preventive) procedures on the urogenital tract (for example, after prolonged catheterization of the bladder). Acute bacterial prostatitis (ABP) is a relatively common disease, with some data indicating it is diagnosed in 10-40% of men.

Chronic bacterial prostatitis is a prostate infection, one of the most challenging urological diseases to diagnose. Recently, this problem has become increasingly relevant as its frequency begins to gradually increase due to various medical, social, and particularly environmental reasons. Globally, according to various data, this disease affects 3% to 16% of the male population aged 20 to 40 years. For instance, in the USA, there are 3 million cases annually.

Chronic nonbacterial prostatitis is a rather specific, severe pathology that does not readily respond to numerous preventive methods currently being studied by specialists. It occurs more frequently relative to other types of prostatitis – in 80-90% of all diagnosed cases of prostatitis.

Asymptomatic inflammatory prostatitis is a chronic inflammatory process that does not manifest itself, remaining unnoticed by the patient for a considerable length of time. It is most often discovered accidentally, in the context of investigations related to other pathologies. However, this does not mean that the disease is entirely safe for men. Some studies point to a possible link between a long-lasting inflammatory process and oncological diseases.

Benign prostatic hyperplasia (BPH) or benign enlargement of the prostate (ICD-10 code – N40) is a chronic, progressive disease of the prostate, closely associated with the aging factor. It involves the enlargement of the gland primarily due to the increase in glandular or stromal components of the organ.

The disease is very common among elderly men and has an unfortunate trend of "becoming younger": it occurs in 10-20% of men under 40 years old and nearly 90% by the age of 80. On average, 20 out of 1000 men will consult a specialist about the symptoms of this disorder by the end of the year, although the actual prevalence of the disease is much higher.

Medical prostate stimulators are effective tools in physiotherapy, magnetotherapy, heat therapy, and therapeutic massage. Although their primary purpose is the mechanical stimulation of the prostate and surrounding tissues to improve blood supply and lymphatic drainage, they have significant advantages over conventional treatment methods (e.g., pharmacological or surgical).